Ontario Drug Benefit Formulary Edition 42

drug products, interchangeability of generic drug products and cost-effectiveness of drugs through its rigorous and evidence-based reviews. These reviews result in recommendations being made to the EO regarding the designation of these products as benefits under the ODB program, and as interchangeable under the DIDFA. The EO ................
................

In order to avoid copyright disputes, this page is only a partial summary.